Annette Regan
- Adjunct Associate Professor of Epidemiology, University of California, Los Angeles
Annette Regan is an epidemiologist with a special interest in vaccines, maternal health, and pregnancy. She completed an MPH in epidemiology at the Rollins School of Public Health, Emory University in 2006, and a PhD in infectious diseases at the University of Western Australia in 2016. Her PhD work focused on the uptake, safety and effectiveness of influenza vaccination during pregnancy in Western Australia and included a large data linkage component, and she has continued interest in the application of linked data for maternal and child health epidemiology, burden of disease, public health surveillance, and cohort studies.
She has previously worked as an epidemiologist for state and federal public health agencies, including the US Centers for Disease Control and Prevention (CDC). During her time at CDC, she coordinated national surveillance activities and had the opportunity to serve in emergency response operations, including the response to the 2009 influenza A/H1N1 pandemic. After leaving CDC in 2011, she spent seven years living in Australia working for the state health department in Western Australia. During her time there, she implemented several communicable disease prevention and surveillance programs, including the development of novel surveillance tools for monitoring emerging infectious disease threats such as Ebola virus.
Since returning to the US in 2018, she has been tenure-track and tenured faculty at the Texas A&M University School of Public Health and the University of San Francisco, where she lectured on epidemiologic methods, infectious disease epidemiology, and reproductive health. Over the course of her career, she has mentored and supervised undergraduate, master's, and doctoral students as well as postdoctoral research fellows. She joined the Fielding School of Public Health (UCLA) in 2019 as Adjunct faculty.
In addition to her public health and teaching experience, Dr. Regan has an active research portfolio in maternal health and immunization and continues to collaborate internationally with researchers in Australia, Norway, Canada, and across the US. She has published >130 peer-reviewed papers in public health and medical journals, including the Lancet, Lancet Global Health, Lancet Infectious Diseases, American Journal of Epidemiology, and the American Journal of Public Health. Her research has contributed to policy briefs and improvements in public health programs related to maternal and child health.
Experience- 2019–present Adjunct Assistant Professor, UCLA 2024–present Research Scientist II, Kaiser Permanente Southern California 2023–2024 Associate Professor (tenured), University of San Francisco 2020–2023 Assistant Professor, University of San Francisco 2018–2020 Assistant Professor, Texas A&M University 2018–2019 NHMRC Early Career Research Fellow, Curtin University 2016–2018 Research Fellow, Curtin University 2012–2016 PhD Candidate, University of Western Australia 2013–2016 Vaccine Epidemiologist, Western Australia Department of Health 2007–2011 Epidemiologist, US Centers for Disease Control and Prevention 2006–2007 Health Care Analyst II, Northrop Grumman (CTR to CDC)
- 2016 School of Pathology and Laboratory Medicine, University of Western Australia, PhD, Infectious Diseases 2016 School of Pathology and Laboratory Medicine, University of Western Australia, Masters of Infectious Diseases 2006 Rollins School of Public Health, Emory University, Masters in Public Health, Epidemiology 2004 University of Florida, Bachelors of Science, Psychology
- 2022 Evaluating teen-parent dynamics in adolescent COVID-19 vaccine acceptance and uptake Role: PI Funding Source: National Institute of Child Health and Human Development 2022 Support for analysis of global influenza and COVID-19 vaccine effectiveness evaluation Role: IPA Recipient Funding Source: Centers for Disease Control and Prevention 2022 Uptake, safety and effectiveness of COVID-19 vaccines during pregnancy Role: PI Funding Source: National Institute of Allergy and Infectious Diseases 2019 Support for analysis of influenza vaccine clinical trial in healthcare personnel Role: IPA Recipient Funding Source: Centers for Disease Control and Prevention 2019 Predictors and barriers to achieving immunization in rural and urban areas Role: PI Funding Source: Health Resources and Services Administration 2018 Informing vaccination strategies for pregnant women through linked population health data Role: PI Funding Source: National Health and Medical Research Council 2018 Links2HealthierBubs: Influenza and pertussis vaccine effectiveness and safety in pregnancy Role: PI Funding Source: National Health and Medical Research Council 2016 Multi-country investigation of influenza vaccine effectiveness in preventing hospitalization and other adverse outcomes associated with influenza among pregnant women Role: Subawardee Funding Source: Centers for Disease Control and Prevention
- Society for Epidemiologic Research Society for Pediatric and Perinatal Epidemiologic Research American Public Health Association Infectious Disease Society of America
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment